Format

Send to

Choose Destination
Diabetes Care. 2015 Nov;38(11):e182-3. doi: 10.2337/dc15-1331. Epub 2015 Aug 26.

Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes.

Author information

1
Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France INSERM, UMRS 911, Marseille, France.
2
Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
3
Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
4
Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France Faculty of Medicine, Aix-Marseille University, Marseille, France INSERM, UMR 1062, Marseille, France.
5
Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France Faculty of Medicine, Aix-Marseille University, Marseille, France INSERM, UMR 1062, Marseille, France Institut National de la Recherche Agronomique, UMR 1260, Marseille, France sophie.beliard@ap-hm.fr.
PMID:
26310693
DOI:
10.2337/dc15-1331

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center